A mutation\'s effect on phenotype commonly depends on the presence or absence of other mutations in the genome, a phenomenon called epistasis. This word was coined 100 years ago by [@b3] to describe departures from the Mendelian 9:3:3:1 ratios expected in the F~2~ generation of a dihybrid cross involving unlinked loci ([@b50], [@b51]). The principled analyses of such departures can yield insights into the mechanisms that determine phenotype ([@b2]; [@b20]; [@b57]). For example in the blue-eyed Mary (*Collinsia parviflora*), crossing true-breeding plants with white and magenta flowers yields 100% blue flowers in the F~1~, and blue, magenta, and white flowers at ratios 9:3:4 in the F~2~. Thus, a mutation at one locus is masked in organisms homozygous mutant at the other, implying that the gene product of the masked locus acts downstream of the gene product of the masking locus.

Mendelian phenotypes are discrete, but epistasis is also widespread in continuous phenotypes and has important implications for human medicine, agriculture, and evolutionary biology ([@b38]). Population genetics traditionally define epistasis for fitness between two mutations *i* and *j* as

where *W~x~* is the absolute fitness of an organism carrying mutation(s) *x* and *W*~0~ is the fitness of the ancestor. We further partition epistasis (ε ≠ 0) into positive and negative epistasis (meaning that the fitness of the double-mutant is higher and lower, respectively, than expected).

The principled analyses of the sign of fitness epistasis between deleterious mutations in pairs of genes can also yield insights into the topology of an organism\'s metabolic network. Building on the metabolic control analysis of [@b26], [@b65] showed that mutations in pairs of genes whose products act in the same linear pathway should exhibit positive epistasis, whereas mutations in pairs of genes whose products act in parallel, redundant pathways should exhibit negative epistasis ([@b60]; D. M. Weinreich, unpubl. ms.). Recently, this reasoning has been used with remarkable success to correctly reconstruct metabolic networks from microbial growth rate data for pairwise gene deletions estimated computationally ([@b60]) or measured experimentally ([@b12]; [@b24]).

Although metabolic control analysis suggests that deleterious mutations in the same gene should only exhibit negative fitness epistasis ([@b65]), experimental work illustrates that the situation is more complicated (e.g., [@b35]; [@b75]; [@b6]; [@b34]). Indeed, these results have stimulated experimental interest in developing a quantitative understanding of how mechanistically more proximal phenotypes drive protein evolution (the functional synthesis of [@b15]). We therefore sought a theoretical perspective complementary to this recent empirical work. We were specifically motivated by the fact that in many systems high-throughput reverse genetics and fitness assays are now practical, whereas the dissection of the underlying molecular biology of fitness effects remains more challenging. Our approach yields insight into more proximal determinants of fitness using only data on pairwise epistasis between deleterious mutations.

We begin here from the observation ([@b74]) that a principled model of protein evolution first proposed by [@b16]; see also [@b10]; [@b21]; [@b67]) bears strong formal similarities to Fisher\'s geometric model ([@b19]; hereafter the FGM). The FGM maps from an abstract representation of the space of all conceivable organismal phenotypes to fitness, and recently Martin et al. ([@b42]; [@b41]; [@b11]) have developed quantitative predictions for patterns of pairwise fitness epistasis under the premise of this abstract phenotypic space. We inverted this logic by asking whether data on fitness epistasis might allow us to quantitatively characterize the actual phenotypic space of the FGM in specific experimental systems. Note too that although motivated by a model of protein evolution, our approach can be applied at any level of organismal organization.

We first present a novel analytic framework that uses epistatic interactions to characterize pairs of deleterious mutations with respect to similarity of phenotypic effect in the FGM. In addition, given data on pairwise epistatic interactions among some set of deleterious mutations, our framework yields an estimate of the total number of mutationally labile dimensions in the phenotypic space of the corresponding FGM. We then use computer simulations to explore the robustness of results to violations of analytic assumptions. Finally, we examine several published datasets. Taken together this study offers a novel theoretical complement to ongoing efforts at dissecting the phenotypic determinants of fitness as well as a quantitatively rigorous examination of Fisher\'s geometric model.

PROTEIN EVOLUTION AND FISHER\'S GEOMETRIC MODEL
===============================================

[@b16] assert three facts about protein biology. First, that in addition to affecting functional properties (e.g., catalytic activity of an enzyme or binding specificity of a transcription factor), mutations in protein coding genes influence organismal fitness via several other molecular phenotypes. These may include gene transcription and message translation rates, the protein\'s native-form folding kinetics and thermodynamics, and its misfolding, aggregation, and degradation rates. Second, many of these phenotypes are commonly under stabilizing selection, that is intermediate values are optimal. For example, although too little folding stability might render most copies of an enzyme nonfunctional, too much stability will also hinder function ([@b40]) as some flexibility, termed "breathing," is essential. ([@b80]; [@b71]; [@b68]) (But see [@b4]; [@b79] for an alternative perspective.) Finally, many mutations act pleiotropically within a protein (e.g., [@b54]; [@b63]; [@b71]; [@b68]). Thus, [@b16] argue that protein evolution is influenced by stabilizing selection acting on multiple phenotypes responding pleiotropically to mutation. Those authors note that fitness epistasis emerges as a consequence of the nonlinear mapping from phenotype to fitness inherent in stabilizing selection (see also [@b7]; [@b41]).

These facts are illustrated in [Figure 1](#fig01){ref-type="fig"} with data for two missense mutations in the TEM-1 β-lactamase allele, responsible for bacterial resistance against β-lactam drugs such as penicillin and cephalosporins. Introducing the G238S mutation (representing serine for glycine at residue 238; amino acid numbering as in [@b1]) into the TEM-1 allele increases resistance against the drug cefotaxime ([@b71]; [@b75]). *In vitro* this mutation increases catalytic activity against this drug ([@b53]; [@b63]; [@b71]), but it reduces thermodynamic stability ([@b54]; [@b71]). In contrast, the M182T mutation reduces cefotaxime resistance when introduced into TEM-1 but increases resistance in the presence of G238S ([@b71]; [@b75]). M182T reduces *in vitro* activity while increasing stability ([@b25]). Thus, interplay between the pleiotropy of these mutations is thought to render M182T conditionally beneficial because the double mutant enjoys increased hydrolysis ([@b71]) without loss of stability ([@b25]). (See [@b76], [@b75] for the evolutionary significance of conditionally beneficial or "sign epistatic" mutations.)

![Effect of two β-lactamase mutations on cefotaxime drug resistance (minimum inhibitory concentration, in μg/mL), catalytic activity (*k*~cat~/*K*~M~ in M^−1^·s^−1^), *~­~*and thermodynamic folding stability (Δ*G* in kcal/mol). Values relative to the TEM-1 wild-type allele. M182T only conditionally improves cefotaxime resistance: it reduces drug resistance (gray bars) on the TEM-1 background but increases it sharply in the presence of G238S. (Data from [@b71]; [@b75]; see [@b76] for the evolutionary implications of such epistasis.) In contrast, note that for both mutations the effect on catalytic activity and thermodynamic folding stability is roughly additive. Figure adapted from [@b74].](evo0067-2957-f1){#fig01}

Fisher\'s geometric model ([Fig. 2](#fig02){ref-type="fig"}A) begins from the premise that the fundamental attribute of adaptation are the many simultaneous "features of conformity" ([@b19], p. 38), both within an organism and between the organism and its environment. Fisher first imagined a continuous, multidimensional phenotype space; any organism can be represented by some point in this space. The biologically optimal combination of phenotypes is at the origin, and fitness elsewhere is a declining function of the distance to the origin. Thus, stabilizing selection acts simultaneously on multiple phenotypes. Second, Fisher assumed that mutations displace an organism in an arbitrary direction in phenotype space; i.e., mutations usually act pleiotropically. Thus, the FGM captures the essential elements of protein evolution outlined above ([@b74]), and this point is illustrated qualitatively in [Figure 2](#fig02){ref-type="fig"}B for the G238S and M182T mutations of the TEM-1 allele of β-lactamase. The FGM is one of the few phenotypic models of evolution (reviewed in [@b46]) and has received extensive theoretical ([@b27]; [@b22]; [@b23]; [@b44], [@b45], [@b47]; [@b48]; [@b52]; [@b77]; [@b73]; [@b42]; [@b72]; [@b61]; [@b11]; [@b32]; [@b62]) and experimental ([@b9]; [@b41]; [@b66]; [@b39]; [@b56]) attention.

![Fisher\'s geometric model of adaptation for *n* = 2 phenotypes. (A) All combinations of phenotype values are represented in *n*-dimensional space (here, the plane); the optimal value is represented by the point labeled *z*~opt~ and an individual-labeled *z* is displaced from this optimum (as perhaps following an environmental perturbation). To be beneficial, a mutation *dz* on wild-type *z* must yield a phenotype *z* + *dz* lying within the circle passing through *z* and centered at *z*~opt~. Inset: *y* represents another organism with fitness equal to that of *z*. Note, however, that mutation *dz* is seen to exhibit epistasis: it is beneficial on *z* but deleterious on *y*. (B) Mutational interactions in TEM-1 β-lactamase between catalytic activity and thermodynamic stability in determining cefotaxime resistance (see [Fig. 1](#fig01){ref-type="fig"}), represented qualitatively in Fisher\'s geometric model. Figure adapted from [@b74].](evo0067-2957-f2){#fig02}

Together these facts motivate this study, which explores pairwise epistasis for fitness between deleterious mutations under the FGM. Specifically any two mutational vectors in phenotype space define an angle θ between them, and θ influences their fitness epistasis as illustrated in [Figure 3](#fig03){ref-type="fig"}A and B. We now invert this logic to make inferences about the geometry of the phenotypic space defined by the FGM from data on epistasis for fitness between deleterious mutations.

![Phenotypic angle θ between mutations *dz~i~* and *dz~j~* under Fisher\'s geometric model. Placing any two mutational vectors *dz~i~* and *dz~j~* on a common ancestral phenotype defines a plane and an angle θ between vectors. (A, B) ∥*dz~i~*∥ and ∥*dz~j~*∥ are both constant, where ∥*x*∥ is the norm of vector *x* defined as *x*^T^*S*x. Thin circles have radii ∥*dz~i~*∥ and ∥*dz~j~*∥; heavy circles have radii ∥*dz~i~*+*dz~j~*∥. Note dependence of ∥*dz~i~*+*dz~j~*∥ (and hence, of epistasis) on θ. (C) Maximum and minimum values of ∥*dz~i~*+*dz~j~*∥ allowed under the model ([eq. 5](#m1){ref-type="disp-formula"}) correspond respectively to θ = 0° and 180°. Experimental error in fitness assays and violations of model assumptions can yield imaginary estimates of θ. Specifically when Max(∥*dz~i~*∥, ∥*dz~j~*∥) − Min(∥*dz~i~*∥, ∥*dz~j~*∥) \> ∥*dz~i~*+*dz~j~*∥, the phenotypic vector representing *dz~i~*+*dz~j~* is inferred to lie inside the inner heavy circle and the arccos(·) in [equation 5](#m5){ref-type="disp-formula"} will yield θ~FGM~ values of the form 180° + *ci*. Conversely, when ∥*dz~i~*+*dz~j~*∥ \> ∥*dz~i~*∥ + ∥*dz~j~*∥, this vector is inferred to lie outside the outer heavy circle and θ~FGM~ will be of the form 0° + *ci*. (D) Real (dashed) and imaginary (solid) parts of θ = arccos(*x*)·180°/π. Note that in any case we can view results as lying on a single continuum: as already suggested in C: values of θ~FGM~ of the form 0° + *ci* lie beyond θ = 0° and values of θ~FGM~ of the form 180° + *ci* lie beyond θ = 180°. See Results and Discussion for further details.](evo0067-2957-f3){#fig03}

Methods
=======

COMPUTING PHENOTYPIC ANGLE Θ BETWEEN MUTATIONS UNDER FISHER\'S GEOMETRIC MODEL
------------------------------------------------------------------------------

We begin by making two assumptions: that fitness is a Gaussian function of phenotypic distance from the optimum, and that phenotypic space is a vector space, that is that mutations are additive in phenotype space (e.g., [@b30]; [@b42]; [@b41]; but see computer simulations later). The first assumption approximates many functions close to the optimum ([@b30]; [@b73]; [@b42]). The second assumption is equivalent to supposing that epistasis acts only on fitness and not on underlying phenotypes. There is good empirical support for this assumption among missense mutations in proteins ([@b35]; [@b79]; although see [@b78] for an important counterexample) and moreover recent theoretical results were found to be robust to its violation ([@b41]).

Following Martin et al. (2007; see also [Fig. 2](#fig02){ref-type="fig"} here), given *n* phenotypes under selection, we represent each organism by a column vector ***z*** whose *i*th component (1 ≤ *i* ≤ *n*) gives the organism\'s deviation at the *i*th phenotype from the optimal value. (Thus, the optimal phenotype ***z***~opt~ is the column vector of all zeros.) Similarly, we represent mutations by column vector ***dz***, whose *i*th component gives the mutation\'s perturbation of the *i*th phenotype. Writing the ancestral organism\'s phenotype ***z***~0~, the absolute fitness of an offspring carrying mutation ***dz*** is then

where superscript T represents transposition and ***S*** is the positive semidefinite *n* × *n* selective covariance matrix. For notational convenience, we shall also sometimes employ log-transformed absolute fitness

Now writing the weighted inner product 〈***dz~i~***, ***dz~j~***〉 = ***dz~i~***^T^***Sdz~j~*** and corresponding vector norm ∥***dz~i~***∥^2^ = 〈***dz~i~***, ***dz~i~***〉 = ***dz~i~***^T^***Sdz~i~***, the phenotypic angle between two mutational vectors ***dz~i~*** and ***dz~j~*** is defined by

the right-hand side of which can in some cases be written in terms of empirical fitness data. To see this note first that under [equation 3](#m3){ref-type="disp-formula"}, *w*(***z***~**0**~ + ***dz****~**i**~* + ***dz****~**j**~*) + *w*(***z***~**0**~) − *w*(***z***~**0**~ + ***dz****~**i**~*) − *w*(***z***~**0**~ + ***dz****~**j**~*) = −***dz****~**i**~*^T^***Sdz****~**j**~*. This expression captures the epistasis between mutations ***dz****~**i**~* and ***dz****~**j**~*, and while slightly different than the classical definition (our [equation 1](#m1){ref-type="disp-formula"}, it is identical to *e~**ij**~* of Martin et al. (2007; see their [eq. 2](#m2){ref-type="disp-formula"}, although that derivation is given in terms of relative rather than absolute fitnesses; see also [@b5]). Importantly, assuming a Gaussian fitness function this empirical expression for ***dz****~**i**~*^T^***Sdz****~**j**~* is correct for all ancestral phenotypes ***z***~**0**~ because it simply reflects the (invariant) curvature of the function, as already noted ([@b41]). In contrast the denominator of [equation 4](#m4){ref-type="disp-formula"} can be expressed in terms of empirical fitness data only by assuming ***z***~**0**~ = ***z***~opt~. In this case, we invert our [equation 3](#m3){ref-type="disp-formula"} to find 2*w*(***dz****~**i**~*) = −***dz****~**i**~*^T^***Sdz****~**i**~*. Substituting these results into [equation 4](#m4){ref-type="disp-formula"} yields as the phenotypic angle between mutations ***dz****~i~* and ***dz****~j~*.

[Equation 5](#m5){ref-type="disp-formula"} thus uses fitness data to give insight into the phenotypic space defined by the FGM; we write θ~FGM~ to highlight this connection. Specifically, the cosine of θ~FGM~ is [@b41]\'s epistasis *e~ij~* between mutations *i* and *j*, normalized by the magnitude of their individual effects. Consequently pairs of strongly epistatic mutations are parallel or antiparallel in phenotype space (i.e., have correlated phenotypic effects, although the converse is not true in general; see Results).

Importantly, our norm in phenotypic space must obey the triangle and reverse triangle inequalities:

These bounds correspond respectively to θ = 180° and θ = 0° and are shown as heavy lines in [Figure 3](#fig03){ref-type="fig"}C. Violating this assumption (here as a consequence of experimental error in fitness assays or violations of assumptions leading to [eq. 4](#m4){ref-type="disp-formula"}) causes the expression inside the curly brackets of [equation 5](#m5){ref-type="disp-formula"} to fall outside the interval \[−1, 1\] and will yield imaginary values of θ~FGM~.

However as illustrated by [Figure 3](#fig03){ref-type="fig"}D, all real and imaginary values of θ~FGM~ lie on a continuum: values of θ~FGM~ of the form 0° + *ci* are simply more extreme than θ = 0° and values of θ~FGM~ of the form 180° + *ci* are simply more extreme than θ = 180°. (Here *i* is the imaginary unit defined by (−1)^½^ and *c* is some real constant.) We therefore treat such observations as categorical data lying on either side of the continuous interval \[0°, 180°\].

COMPUTING THE NUMBER OF PHENOTYPIC DIMENSIONS FROM FITNESS DATA
---------------------------------------------------------------

The distribution of values of θ~FGM~ observed also contains information about *n*, the number of mutationally labile dimensions in the underlying phenotype space. It has previously been shown that that the probability density function for angles θ between some reference direction and a set of vectors of random orientation in an *n*-dimensional space is

([@b23]; [@b52], where *Z* is the scaling constant required to get a proper probability density function over \[0°, 180°\]). This is also the probability density function for θ between vectors sampled from a multivariate Gaussian distribution with mean 0 and covariance matrix ***M*** = *c*·***I***, where *c* is any positive scalar and ***I*** is the identity matrix (not shown). Thus, assuming this sampling scheme, [equation 7](#m7){ref-type="disp-formula"} gives the expected distribution of θ~FGM~ between some focal mutation ***dz****~i~* and all others in the dataset. But because this distribution is independent of the choice of focal mutation, it applies equally to the unconditioned distribution of θ~FGM~ across an entire dataset. After discarding imaginary values of θ~FGM~ we thus employed this density function in a likelihood framework to estimate together with 95% confidence intervals (CIs).

COMPUTER SIMULATION
-------------------

Computer simulations were run using MATLAB R2011a (Mathworks, Natick, MA) to confirm analytical results and to explore the effect of experimental noise in fitness assays and relaxations of model assumptions. All code has been archived at <https://github.com/weinreich/FGM-FunctionalSynthesis>. Following [@b42], [@b41]), we assume that the mutational probability density function is Gaussian with covariance matrix ***M***. For the purpose of exploring the robustness of [equation 5](#m5){ref-type="disp-formula"} we further assume a rotationally symmetric mutational covariance matrix ***M*** = *m* × ***I*** (because its derivation is independent of ***M***) with standard deviation *m* = 0.1 phenotypic units. We relaxed this assumption to assess our ability to estimate phenotypic dimensionality. Because [equation 5](#m5){ref-type="disp-formula"} is also independent of selection matrix ***S***, we set ***S*** = ***I*** throughout.

SENSITIVITY OF ESTIMATES OF PAIRWISE PHENOTYPIC ANGLE θ~FGM~
------------------------------------------------------------

In each run, we sampled 200 random mutational vectors ***dz****~i~* and ***dz****~j~* and computed θ~true~ between each of the resulting pairs of mutations using [equation 4](#m4){ref-type="disp-formula"} and ***S*** = ***I***. We then tabulated the mean and standard deviation for corresponding values of θ~FGM~ (as described next) within a sliding window of θ~true~ values 10° wide. We also tabulated the frequency of each kind of imaginary value of θ~FGM~ observed in each sliding window.

To explore the sensitivity of [equation 5](#m5){ref-type="disp-formula"} to experimental noise in fitness assays, we first added a normal deviate with mean zero and standard deviation σ~noise~ to fitness [equation 2](#m2){ref-type="disp-formula"}. For each pair of mutations, we then computed θ~FGM~ with [equation 5](#m5){ref-type="disp-formula"} using the average of *R* replicate noisy fitness measures for each mutational vector. We explored values of experimental noise σ~noise~ = 0.01 and 0.02, experimental replication *R* = 10 and 40, and phenotypic dimensions, *n* = 2, 5, and 20. Because fitness values in our simulations are in the range of 0.8--1.0 (not shown), values of σ~noise~ here are roughly comparable to the CV values shown in Table[1](#tbl1){ref-type="table"} (experimental standard error normalize by experimental mean values, see Analysis of Empirical Data). Simulated levels of replication are consistent with current experimental protocols (e.g., [@b59]), and simulated phenotypic dimensionality values are consistent with estimates here ([Fig. 6](#fig06){ref-type="fig"}) and elsewhere ([@b66]).

###### 

Published biological datasets analyzed

                                                          Number of                                                                                                                       
  ------------------------------------------------------- ----------- --------------- -------------------------------------------------------- ------------------------------------------ -----------------------------------
  *Escherichia coli*, isopropylmalate dehydrogenase       6           Site-directed   Chemostat competition assay against the wild-type        0.0037^[1](#tf1-1){ref-type="table-fn"}^   Lunzer et al. ([@b35], b)[@b36]
  *Escherichia coli*, β-lactamase                         5           Site-directed   Minimum inhibitory concentration against cefotaxime      0.087                                      [@b75]
  *Plasmodium falciparum* dihydrofolate reductase         4           Site-directed   Minimum inhibitory concentration against pyrimethamine   No data reported                           [@b34]
  *Escherichia coli*, gyrA, rpoB, and rpsL                3           Random          Paired growth assays against the wild-type in LB         0.68                                       Trindade et al. ([@b69], b)[@b70]
  *Eschericia coli,* Mini-Tn10 mutants                    8           Random          Paired growth assay against ancestor in DM25             0.018                                      Elena and Lenski ([@b17], [@b18])
  Vesicular stomatitis virus N, P, M, G, and L            28          Random          Intrinsic growth rate in mammalian cell culture          0.056                                      [@b59]
  *Aspergillus niger,* arg, pyr, leu, phe, oli, and crn   7           Random          Radial growth rate of colony                             0.030                                      [@b14]

Reported in [@b37].

To test consequences of our assumption that the ancestral phenotype is at the fitness optimum, we also ran simulations in which *W***(*z*~0~)** = 0.99 and 0.90 for phenotypic dimension *n* = 2, 5, and 20. We accomplished this by setting each component of ***z***~0~ to (2ln\[*W***(*z*~0~)**\]/*n*)^½^. To relax the assumption that mutations are additive in phenotype space, we added a phenotypic epistasis vector ***E*** to each double mutant before applying [equation 2](#m2){ref-type="disp-formula"}. Each component of ***E*** was drawn from a normal distribution with mean 0 and standard deviation σ~epistasis~, parameterized as a proportion of mean mutational vector length *m*. Values of σ~epistasis~ = 0.1*m* and 0.5*m* were examined.

SENSITIVITY OF ESTIMATES OF PHENOTYPIC DIMENSIONALITY *n*
---------------------------------------------------------

To explore the sensitivity of our approach to estimating phenotypic dimensionality *n* in the face of experimental noise and violations of model assumptions, we simulated samples of 10 or 25 mutations each, setting *n* = 2, 5, or 20, and allowing experimental noise in fitness assays, nonoptimal ancestral phenotypes, or phenotypic epistasis as described earlier. We also examined violations of the assumption of rotational symmetry in mutational matrix ***M*** underlying [equation 7](#m7){ref-type="disp-formula"}. Here again, samples of 10 or 25 mutations were generated in *n* = 2, 5, or 20 dimensions with mutational matrix ***M*** = *m* × ***I*** as above, except that we set matrix entries *m*~1,1~ = *m*/2, or *m*~1,2~ = *m*/2, or both.

For each sample, we discarded imaginary values of θ~FGM~, calculated the likelihood surface for a range of values of *n* between 2 and 40 in steps of 0.05, and recorded the maximum likelihood estimate together with the 95% CI bounds. These simulated datasets are comparable in size (10 and 25 mutations yield at most 45 and 300 comparisons, respectively) and phenotypic dimensionality to those in Table[3](#tbl3){ref-type="table"}.

DATA ANALYSIS
-------------

Theoretical results developed here were applied to the seven published datasets shown in Table[1](#tbl1){ref-type="table"}. Only deleterious mutations described in Elena and Lenski ([@b17], [@b18]) and [@b59] were considered, and in all datasets lethal mutations were removed (as required by [eq. 4](#m4){ref-type="disp-formula"}; for this reason we analyzed MIC values presented in [@b34] rather than IC~50~ values). We then used [equation 5](#m5){ref-type="disp-formula"} to compute θ~FGM~ between all pairs of remaining mutations in each dataset, and the number of dimensions of the underlying phenotypic space was estimated as described. Finally, we used the Kolmogorov--Smirnov goodness-of-fit test ([@b64]) as implemented in Matlab to compare the observed distributions of θ~FGM~ for each dataset with model expectations ([eq. 6](#m6){ref-type="disp-formula"}) for given .

Results
=======

Under analytic assumptions, Fisher\'s geometric model allows us to use epistasis for fitness between pairs of deleterious mutations to characterize those pairs with respect to similarity of underlying mechanism. Specifically, pairs of mutations with very similar mechanisms will exhibit strong epistasis and values of θ~FGM~ near 0° or 180°, although the converse need not be true. (As the numerator of [eq. 3](#m3){ref-type="disp-formula"} illustrates, epistasis will only be absent if the two mutational vectors are orthogonal in the space defined by matrix ***S***, but such mutations will only exhibit uncorrelated phenotypes if all off-diagonal elements of ***S*** are 0.) Moreover, the distribution of epistasis across a panel of deleterious mutations can yield an estimate of the number of mutationally labile phenotypes contributing to fitness.

ESTIMATING θ~FGM~ WHEN ANALYTIC ASSUMPTIONS ARE RELAXED
-------------------------------------------------------

Under analytic assumptions (i.e., setting σ~noise~ = σ~epistasis~ = 0, ***z***~0~ = ***z***~opt~ and random positive semidefinite ***S***) simulation results were precisely concordant with [equation 5](#m5){ref-type="disp-formula"} for all parameter values examined (not shown). [Figures 4](#fig04){ref-type="fig"} and [5](#fig05){ref-type="fig"} present simulation results that explore sensitivity of [equation 5](#m5){ref-type="disp-formula"} to experimental noise and to relaxing model assumptions, respectively. Each panel displays the mean real θ~FGM~ values (± 1 SD) across a sliding window of θ~true~ values 10° wide. In addition, we show the frequency of each of the two classes of imaginary values of θ~FGM~ observed each in each sliding window. Finally, in each panel, we report the *r*^2^ value for a linear regression of real estimates of θ forced through the origin (see Discussion).

![Estimation of θ~FGM~ in computer simulations allowing experimental error in fitness assay. [Equation 5](#m5){ref-type="disp-formula"} can return real and imaginary values. Heavy lines represent mean ±1 SD of real values of θ~FGM~ ([eq. 4](#m4){ref-type="disp-formula"}) for a given θ~true~ (computed with [eq. 3](#m3){ref-type="disp-formula"}) in a sliding window 10° wide; heavy dashed line represents θ~FGM~ = θ~true~. (Scale on left y-axis.) Light lines represent fraction of imaginary values of θ~FGM~\'s in the same sliding window (solid: frequency of imaginary θ~FGM~ with real part = 0°; dashed: frequency of imaginary θ~FGM~\'s with real part = 180°; scale on right y-axis). All parameter values as shown (phenotypic dimensionality *n*, experimental noise σ~noise~, experimental replicates *R*). Phenotypic epistasis (σ~epistasis~) equal to 0, *z*~0~ = *z*~opt~, and *S* = *I*.](evo0067-2957-f4){#fig04}

![Estimation of θ~FGM~ in computer simulations when model assumptions are relaxed. (A) Relaxing *z*~0~ = *z*~opt~. (B) Relaxing phenotypic additivity. Note that as *n* increases, values of θ~true~ become increasingly concentrated around 90° ([@b23]; [@b52]). See [Figure 4](#fig04){ref-type="fig"} legend for additional details.](evo0067-2957-f5){#fig05}

We note first that in all cases, imaginary values of θ~FGM~ of the form 0° + *ci* are primarily observed when θ~true~ is small, whereas imaginary values of the form 180° + *ci* are associated with large values of θ~true~. This is to be expected given our proposed interpretation of such observations ([Fig. 3](#fig03){ref-type="fig"}D). Moreover, conditioned on θ~FGM~ being real, θ~FGM~ almost always overestimates θ~true~ when θ~true~ is small and underestimates it when large. This is a simple consequence of our conditioning: the "missing," more extreme estimates of θ~FGM~ are to be found in the imaginary realizations. Finally, in almost all cases summing across all values of θ~true~, the frequency of imaginary values of θ~FGM~ of the form 0° + *ci* exceeds the frequency of values of the form 180° + *ci*. This can be understood by examining [Figure 3](#fig03){ref-type="fig"}C, which illustrates that for all parameter values the area outside the larger heavy circle \[representing ∥***dz****~i~*∥ + ∥***dz****~j~*∥)\] exceeds that inside the smaller heavy circle \[representing Max(∥***dz****~i~*∥, ∥***dz~j~***∥) -- Min(∥***dz****~i~*∥, ∥***dz~j~***∥)\]. Put another way, experimental noise and violations of model assumptions perturb our estimate of where the vector ***dz****~i~* + ***dz****~j~* lies. But when θ~true~ is near 180° such perturbation is less likely to result in an imaginary estimate of θ~FGM~ than when it is near 0°.

[Figure 4](#fig04){ref-type="fig"} illustrates that conditioning on the observation of real values of θ~FGM~, [equation 5](#m5){ref-type="disp-formula"} can estimate θ~true~ quite well from modestly noisy fitness data. Strong, nearly unbiased predictive power is observed in the first panel and standard deviation declines as phenotypic dimension increases (the trend continues for *n* = 20; not shown). This can be understood as a consequence of two facts. First, as dimension increases the probability distribution of realized θ~FGM~ becomes increasingly concentrated around 90° ([@b22]; [@b52]; see also [Figs. 5](#fig05){ref-type="fig"}, [6](#fig06){ref-type="fig"} here). This alone accounts for the drop in frequency of imaginary values of θ~FGM~ as dimension rises. Second, because ***S*** = ***I*** in simulations, as θ~FGM~ approaches 90° *W*(***dz****~i~* + ***dz****~j~*) approaches *W*(***dz****~i~*)*W*(***dz****~i~*). Thus, even after allowing noise in fitness assays, the numerator of the expression inside curly braces in [equation 5](#m5){ref-type="disp-formula"} will tend to be small, minimizing the standard deviation in θ~FGM~. Increasing experimental error (σ~noise~) increases standard deviation of θ~FGM~ for all values of θ, although as expected this effect can be offset by additional fitness assay replicates (*R*).

![Frequency of real pairwise angles between pairs of deleterious mutations in published datasets shown in Table[1](#tbl1){ref-type="table"}. Filled: θ~FGM~ computed with [equation 5](#m5){ref-type="disp-formula"}. Open: expectation as described, corresponding to phenotypic dimensionality estimated for each dataset. (A) Lunzer et al. (2005a, b), (B) [@b75], (C) [@b34], (D) Trindade et al. (2009a, b), (E) Elena and Lenski(1997a, b), (F) Sanjuan et al (2004), (G) de [@b14], (H) Bottom-up estimates of θ~FS~ derived from [@b36]. (See text for details.)](evo0067-2957-f6){#fig06}

Sensitivity of [equation 5](#m5){ref-type="disp-formula"} to violations of two assumptions is explored in [Figure 5](#fig05){ref-type="fig"}. [Figure 5](#fig05){ref-type="fig"}A illustrates that when the ancestor is not at the phenotypic optimum (i.e., ***z***~0**­**~ ≠ ***z***~opt~), values of θ~FGM~ are skewed toward intermediate values. As noted earlier, this effect is entirely the result of errors introduced through the denominator of [equation 5](#m5){ref-type="disp-formula"} because −***dz****~i~*^T^***Sdz****~j~* is only equal to 2ln\[*W*(***dz****~i~*)\] when ***z***~0**­**~ = ***z***~opt~. Consequently, the magnitude of the effect is seen to increase as the fitness of ***z***~0~ declines. However, the effect is moderated with increasing phenotypic dimension because the phenotypic perturbation introduced by any given fitness drop in ***z***~0~ is proportional to *n*^−½^.

[Figure 5](#fig05){ref-type="fig"}B illustrates the consequences of phenotypic epistasis. Again, increased deviations from model assumptions increase the error in [equation 5](#m5){ref-type="disp-formula"}. We also note that in contrast to the situation in [Figure 5](#fig05){ref-type="fig"}A, increasing phenotypic dimensions render results more sensitive to violations of model assumptions. This is to be expected as we add a normally distributed random deviate to each component of the double-mutant\'s phenotype. Thus, the net error in ***z***~0~ + ***dz****~i~* + ***dz****~j~* is proportional to *n*^½^.

ESTIMATING PHENOTYPIC DIMENSIONALITY *n* WHEN ANALYTIC ASSUMPTIONS ARE RELAXED
------------------------------------------------------------------------------

Sensitivity of our estimator for phenotypic dimensionality in the face of experimental noise and violation of model assumptions is shown in Table[2](#tbl2){ref-type="table"}. In general, we note that the maximum likelihood estimate is a bit below the center of the 95% CI, signaling a slightly positive skew to the likelihood function. We also note a slight bias toward overestimating phenotypic dimensionality in the face of experimental error, most notably when ***z***~0~ ≠ ***z***~opt~. This is to be expected: by conditioning on real values of θ~FGM~ we are discarding realizations that otherwise would have fallen in the tails of the distribution of angles ([Fig. 3](#fig03){ref-type="fig"}), making phenotypic dimensionality appear higher than it is ([eq. 6](#m6){ref-type="disp-formula"}). However, deviations from rotationally symmetric mutations bias dimensionality estimates downward. This is also to be expected: as mutational variance in one dimension is reduced (here, *m*~1,1~ has been reduced from 0.1 to 0.05) mutations will become increasingly skewed in the remaining dimension(s). And similarly, as mutational covariance is increased (here *m*~1,2~ = *m*~2,1~ has increased from 0.0 to 0.05), mutations will more often have a common orientation.

###### 

Maximum likelihood estimate and confidence intervals on phenotypic dimensionality in computer simulations

  True phenotypic dimensionality, *n*                      2                 5                 20                 2                5                20
  -------------------------------------------------------- ----------------- ----------------- ------------------ ---------------- ---------------- ------------------
  Using default values^[1](#tf2-1){ref-type="table-fn"}^   1.95              4.10              17.65              2.00             5.05             18.70
                                                           (1.70 -- 2.35)    (3.45 -- 6.10)    (12.20 -- 24.00)   (1.90 -- 2.10)   (4.50 -- 5.65)   (16.15 -- 21.70)
  σ~noise~ = 0.01, *R* = 10                                2.55              4.75              25.05              2.70             5.10             20.80
                                                           (2.05 -- 3.20)    (3.60 -- 6.45)    (16.80 -- 29.60)   (2.50 -- 2.95)   (4.60 -- 5.75)   (17.90 -- 23.95)
  σ~noise~ = 0.02, *R* = 10                                2.70              5.35              20.75              2.50             4.95             19.15
                                                           (2.20 -- 3.50)    (4.05 -- 7.35)    (14.00 -- 24.65)   (2.30 -- 2.75)   (4.45 -- 5.55)   (16.55 -- 22.20)
  σ~noise~ = 0.02, *R* = 40                                2.35              5.45              15.90              2.30             4.45             20.15
                                                           (1.95 -- 2.95)    (4.10 -- 7.50)    (11.05 -- 23.20)   (2.15 -2.50)     (4.00 -- 4.95)   (17.40 -- 23.35)
  ***W***(***z*~0~**) = 0.99                               2.85              6.15              21.80              3.65             5.10             20.60
                                                           (2.25 -- 3.70)    (4.55 -- 8.50)    (14.95 -- 29.05)   (3.30 -- 4.10)   (4.55 -- 5.70)   (17.75 -- 23.90)
  ***W*(*z*~0~**) = 0.90                                   7.00              12.50             25.20              5.60             7.75             21.90
                                                           (5.00 -- 10.15)   (8.80 -- 18.20)   (17.20 -- 33.85)   (4.90 -- 6.45)   (6.80 -- 8.90)   (18.90 -- 24.45)
  σ~epistasis~ = 0.1*m*                                    2.15              4.45              15.85              2.20             5.00             19.30
                                                           (1.85 -- 2.60)    (3.40 -- 6.00)    (11.05 -- 23.15)   (2.05 -- 2.35)   (4.45 -- 5.65)   (16.70 -- 22.40)
  σ~epistasis~ = 0.5*m*                                    2.50              5.55              25.20              2.75             4.85             19.55
                                                           (2.05 -- 3.20)    (4.15 -- 7.65)    (17.20 -- 33.85)   (2.55 -- 3.05)   (4.35 -- 5.45)   (16.90 -- 22.70)
  *m*~1,1~ = *m*/2                                         1.85              5.05              16.05              1.90             4.45             18.40
                                                           (1.60 -- 2.15)    (3.85 -- 6.90)    (11.15 -- 23.40)   (1.80 -- 2.00)   (4.00 -- 5.00)   (15.90 -- 21.35)
  *m*~1,2~ = *m*~2,1~ = *m*/2                              1.60              3.20              16.15              1.65             3.85             16.55
                                                           (1.45 -- 1.85)    (2.60 -- 4.15)    (11.25 -- 23.60)   (1.60 -- 1.75)   (3.50 -- 4.30)   (14.30 -- 19.15)
  *m*~1,1~ = *m*~1,2~ = *m*~2,1~ = *m*/2                   1.55              5.20              20.35              1.70             4.20             17.45
                                                           (1.40 -- 1.75)    (3.90 -- 7.10)    (14.05 -- 29.90)   (1.65 -- 1.80)   (3.80 -- 4.70)   (15.10 -- 20.25)

Default values used throughout except where noted. σ~noise~ = experimental noise (default: 0.0); *R* = experimental replicates (default: 1), ***W***(***z*~0~**) = fitness of ancestor (default: 1.0), σ~epistasis~ = phenotypic epistasis (default: 0.0*m*), ***M*** = *m* × ***I*** mutational covariance matrix (default: *m* 0.1), selection covariance matrix ***S*** = ***I*** throughout.

ANALYSIS OF EMPIRICAL DATA
--------------------------

We computed θ~FGM~ between all pairs of mutations in each of the seven published datasets shown in Table[1](#tbl1){ref-type="table"}, and used those distributions to compute the estimated phenotypic dimensionality together with the 95% CI, as described. Observed and expected distributions, values and confidence intervals, and *P-*values for goodness-of-fit to [equation 7](#m7){ref-type="disp-formula"} are all shown for each dataset in [Figure 6](#fig06){ref-type="fig"}. Further details of these analyses are provided in Table[3](#tbl3){ref-type="table"}.

###### 

Analyses of published datasets.[1](#tf3-1){ref-type="table-fn"}

                                                                                                            Number of   Number of   Kolmogorov--Smirnov    
  ---------------------------------------------------------------------------------------------------- ---- ----------- ----------- ---------------------- --------
  *Escherichia coli*, isopropylmalate dehydrogenase                                                    67   43          0           0.502, 4.1 × 10^−6^    58.4°
  *Escherichia coli*, β-lactamase                                                                      10   1           0           0.27, 0.46             94.8°
  *Plasmodium falciparum* dihydrofolate reductase                                                      6    1           1           0.59, 0.07             133.0°
  *Escherichia coli*, gyrA, rpoB, and rpsL                                                             98   0           16          0.39, 8.4 × 10^−12^    117.4°
  *Escherichia coli,* Mini-Tn10 mutants                                                                21   6           4           0.37, 0.07             104.5°
  Vesicular stomatitis virus                                                                           31   1           5           0.122, 0.80            92.7°
  *Aspergillus niger,* arg, pyr, leu, phe, oli, and crn                                                14   0           0           0.652, 2.4 × 10^−6^    120.1°
  *Escherichia coli*, isopropylmalate dehydrogenase, bottom-up θ~FS~[2](#tf3-2){ref-type="table-fn"}   67   N/A         N/A         0.422, 4.4 × 10^−11^   77.4°

See Table[1](#tbl1){ref-type="table"} for citations.

Bottom-up estimates based on angles between phenotypic vectors. See text for details.

Discussion
==========

Evolution by natural selection enriches populations for those organisms with higher reproductive success ([@b13]), but what is the underlying biology responsible for these differences? Fitness is a complex property that emerges from many mechanistically more proximal phenotypes, and R.A. Fisher\'s geometric model (1930; here, the FGM) provides a popular, explicit, and abstract representations of that mapping (although see [@b28]; [@b29]; [@b55] for other mappings). Noting the close qualitative parallels to a recent model of protein evolution ([@b16]; see [Fig. 2](#fig02){ref-type="fig"} here), we thought to use the FGM to explore our ability to make inferences into this underlying phenotypic space from data on epistasis for fitness between deleterious mutations. We were motivated by the many low-throughput (e.g., [@b35]; [@b75]; [@b34]) and high-throughput (e.g., [@b12]; [@b24]) datasets now being developed. We sought two practical contributions for the experimentalist: the ability to group mechanistically related mutations (i.e., those with highly correlated phenotypic effects) and the ability to make gross statements about the phenotypic complexity of the system (i.e., the dimensionality of phenotypic space).

INTERPRETING VALUES OF θ~FGM~
-----------------------------

Importantly however, our approach is complicated by the fact that [equation 5](#m5){ref-type="disp-formula"} can return biologically ambiguous results in the form of imaginary values (Table[3](#tbl3){ref-type="table"}). Indeed, all datasets considered here except one ([@b14]) include some imaginary values of θ~FGM~; these range in frequency from 10% ([@b75]) to 64% ([@b35]). In simulations, we observed that imaginary values occur as a consequence of measurement error in fitness assays ([Fig. 4](#fig04){ref-type="fig"}) as well as violations of model assumptions ([Fig. 5](#fig05){ref-type="fig"}). However, no one of these factors appears to fully explain the source of these observations in the data.

Simulations demonstrate that the fraction of imaginary values should rise with experimental error in fitness assays and drop with phenotypic dimensionality ([Fig. 4](#fig04){ref-type="fig"}). We thus first tabulated experimental error (CV) for six of the seven datasets examined (Table[1](#tbl1){ref-type="table"}; no error estimates are given in [@b34]), but contrary to the suggestion from simulation results, the fraction of imaginary values of θ~FGM~ observed is weakly and negatively correlated with experimental CV (*r*^2^ = 7.3%). We next regressed the fraction of imaginary values of θ~FGM~ against our estimated phenotypic dimensionality for each dataset. Although this correlation is also negative, consistent with expectation, it is also only weakly so (*r*^2^ = 17.7%). Thus, although some imaginary values of θ~FGM~ may be the consequence of experimental error in fitness assays, we wondered whether they may not also derive in part from violations of model assumptions: ***z***~0~ = ***z***~opt~, additivity among phenotypic vectors, and a Gaussian fitness function.

For three datasets ([@b35]; [@b14]; [@b70]b), we computed epistasis on a naturally occurring wild-type isolate, which we might reasonably expect to be at or near the (local) fitness optimum, and these studies describe no beneficial mutations on those backgrounds. Two datasets ([@b75]; [@b34]) employ drug resistance as a proxy for fitness, and we computed epistasis on the highest-resistance variant described. Again, these studies describe no beneficial mutations on those backgrounds. (And in one case extensive mutagenesis has failed to reveal a higher-resistance variant; [@b43]; [@b58].) Although beneficial mutations on the ancestor were described in the last two datasets ([@b18]; [@b59]) we believe it is unlikely that ***z***~0~ ≠ ***z***~opt~ is responsible for many of the imaginary values of θ~FGM~ in Table[3](#tbl3){ref-type="table"}. Indeed, in the case where the starting genotype is demonstrably far the fitness optimum ([@b59]), the frequency of imaginary values of θ~FGM~ is comparatively modest.

To our knowledge, data on phenotypic additivity are scarce. One case however comes from Lunzer et al. (2005a,b). In addition to measuring organismal fitness, those authors performed *in vitro* assays for four functionally proximal biochemical phenotypes likely responsible for fitness effects of mutations in their system. They find that mutational effects on log-transformed values of these phenotypes are very nearly additive (*r*^2^ ≥ 0.92). Thus at present, we find little evidence to suggest that phenotypes are not additive.

Finally, we acknowledge that non-Gaussian fitness functions can also give rise to imaginary values of θ~FGM~. Although sensitivity of our approach to this effect has not been explored, principled models of the phenotype-to-fitness function for both IMDH ([eq. 3](#m3){ref-type="disp-formula"} in [@b35]) and β-lactamase ([eq. 4](#m4){ref-type="disp-formula"} in [@b8]) are distinctly non-Gaussian. Following others (e.g., [@b49]; [@b31]) we are presently pursuing an alternative approach that relieves us of the burden of this assumption.

TOP-DOWN VERSUS BOTTOM-UP ESTIMATES OF θ
----------------------------------------

Here we have employed what may be regarded as a top-down approach to quantitatively characterize the phenotypic space underlying the FGM. The functional synthesis ([@b15]) represents a complementary bottom-up approach: characterization of the mechanistically proximal phenotypic traits responsible for fitness effects of particular mutations. As already noted, in addition to fitness Lunzer et al. (2005a, b) characterized mutational perturbation in four candidate proximal phenotypes related to enzyme--substrate affinity and enzyme kinetics. These data allow further examination of [equation 5](#m5){ref-type="disp-formula"}, because we can explicitly represent mutations as phenotypic vectors where Δ is relative to the allele of highest fitness. Application of [equation 4](#m4){ref-type="disp-formula"} to these vectors thus yields independent measures of pairwise angles θ between mutations in phenotypic space. We designate these values θ~FS~ to reflect their connection to the functional synthesis.

To determine how well θ~FS~ predicts θ~FGM~, we regressed the latter on the former ([Fig. 7](#fig07){ref-type="fig"}). Consistent with expectations we observe a significantly positive slope between real values of θ~FGM~ and θ~FS~ (Spearman rank correlation coefficient ρ = 0.408, *P* = 0.024 by a permutation test). The slope of the regression through the origin (0.69) is different from 1.0, although this should perhaps not surprise us because the numeric angle θ between two vectors is sensitive to scaling of phenotypic space. For example, [@b35] report values of *V*~max~/*K~M~* in units of M^−1^·s^−1^; rescaling *V*~max~/*K~M~* in units of mM^−1^·s^−1^ would change all values of θ~FS~ without changing any of the biology. Indeed, we are substantially heartened by this result for two reasons. First, rescaling dimensions of phenotypic space can even perturb rank orders of angles when *n* \> 2. Second, although θ~FS~ offers direct access to mutational vectors in phenotype space, θ~FGM~ values are influenced by the (unknown) asymmetries of the true selection covariance matrix ***S***. [Figure 7](#fig07){ref-type="fig"} also shows that the frequency of imaginary values of θ~FGM~ of the form 0° + *ci* declines as θ~FS~ rises, consistent with model expectations. (No values of θ~FGM~ of the form 180° + *c* were observed in this dataset; Table[3](#tbl3){ref-type="table"}.)

![Bottom-up analysis of phenotypic angles among mutations in isopropylmalate dehydrogenase examined in Lunzer et al. (2005a, b). For each pair of mutations, x--axis represents pairwise phenotypic angle θ~FS~ computed with [equation 4](#m4){ref-type="disp-formula"} using phenotypic perturbations in log-transformed cofactor performance and binding affinity estimated by Lunzer et al. (2005a, b). Left y-axis represents real θ~FGM~ values computed from fitness data using [equation 5](#m5){ref-type="disp-formula"}; dashed line shows linear regression through the origin. Right y-axis represents the fraction of imaginary values of θ~FGM~ in a sliding window 10° wide. Only imaginary θ~FGM~ values of the form 0 + *ci* were observed in this dataset. Cf. [Figures 4](#fig04){ref-type="fig"} and [5](#fig05){ref-type="fig"}.](evo0067-2957-f7){#fig07}

INTERPRETING VALUES OF *n*
--------------------------

Our second objective was to provide some access to the phenotypic complexity underlying fitness. Interestingly, values reported here ([Fig. 6](#fig06){ref-type="fig"}) fall between those previously developed under the FGM by others (0.2--2.5 in [@b42]; and 10--45 in [@b66]; see also [@b33] for an attempt to bridge those divergent estimates). Although [equation 5](#m5){ref-type="disp-formula"} examines curvature of the fitness function at the fitness optimum, [@b42] employ data from mutation accumulation experiments and their results thus characterize the fitness function over a wider mutational scope. Finally, estimates in [@b66] are based on differences in fitness at mutation/selection/drift equilibrium as a function of population size, and may therefore represent the analysis covering the largest genetic scale.

As above, phenotypic data in [@b36] also allow us to perform a bottom-up complement to our top-down estimation of . The distribution of θ~FS~ ([Fig. 6](#fig06){ref-type="fig"}H) implies that these vectors lie in a higher dimensionality space than do results based on θ~FGM~ ([Fig. 6](#fig06){ref-type="fig"}A;  = 10.90 vs. 3.45), although the two distributions are statistically indistinguishable (*G* = 2.45, *P* \> 0.98, df = 9).

A bias in derives from our assumption that mutational vectors are uniformly distributed in phenotypic space. To the extent that they are not, ours are underestimates (Table[2](#tbl2){ref-type="table"}). We thus regard our approach as estimating an "effective" number of dimensions in phenotype space (i.e., the number of dimensions of equal and uncorrelated mutational lability that would give rise to the given distribution of θ~FGM~). Although an analytic analog to [equation 7](#m7){ref-type="disp-formula"} for arbitrary mutational covariance matrix ***M*** appears possible, it would not be helpful here because we would then be faced with estimating both and from single distributions of θ~FGM~.

In addition, because [equation 7](#m7){ref-type="disp-formula"} is undefined when θ is imaginary, it was necessary to omit such values of θ~FGM~ when we estimated phenotypic dimensionality. This protocol biases upward. Recognizing the diversity of datasets in our study, we however observe no signal of this bias: the correlation between and the frequency of imaginary values of θ~FGM~ is in fact weakly negative.

Finally, the distribution of θ~FGM~ deviates significantly from the expectation given by [equation 7](#m7){ref-type="disp-formula"} in three cases ([Fig. 6](#fig06){ref-type="fig"}; Table[3](#tbl3){ref-type="table"}). In one ([@b35], [@b35]), the mean (58.4°) is far less than expectation (as is the mean θ~FS~ from the same system~­~: 77.4°), implying that these mutations are underdispersed in phenotype space. This effect is already visible in [Figure 3](#fig03){ref-type="fig"} of [@b35], which shows that all phenotypic mutations lie in a narrow sector emanating from the wild type. Means are larger than expectation in the other two cases ([@b14]; [@b70]; 120.2° and 117.4°, respectively), implying mutational overdispersion, and we imagine that in these systems ridges of high mutational density radiate from the wild type, separated by valleys of low mutational density approximately 120° wide. Both of these situations imply correlations between mutations (positive in the first case and negative in the latter two; note that these correlations are distinct from correlations within mutations represented by the matrix ***M***), although the biological and evolutionary implications are as yet unclear to us. No particular association between these deviations and the sources of mutations (Table[1](#tbl1){ref-type="table"}) was observed.

CONCLUSIONS
-----------

Using Fisher\'s geometric model we have developed a novel approach to characterizing aspects of the phenotypic determinants of deleterious mutations using data on pairwise epistasis. Despite our original motivation for adopting the FGM ([Fig. 2](#fig02){ref-type="fig"}), we are generally heartened by the apparent utility of our approach when applied to the heterogeneous datasets (Table[1](#tbl1){ref-type="table"}: four from bacteria, two from eukaryotes and one from a virus). Moreover, although growth rate is the fitness assay in five cases, drug resistance is employed in two. And finally, three of the datasets consider mutations in a single gene while the other four use mutations more broadly distributed across the genome.

We conclude by noting that much of evolutionary biology rightly focuses on beneficial mutations, those which fuel adaptation. In contrast, we have only considered epistasis between deleterious mutations, both because they are far more plentiful and because our algebraic framework cannot accommodate beneficial mutations. Moreover statistical patterns of fitness epistasis among deleterious mutations do not always mirror those among beneficial mutations ([@b59]; [@b56]). However, our interest in epistasis here is limited to making inferences into the mechanistically proximal phenotypes underlying mutational effects on fitness. And as it seems reasonable to assume that deleterious and beneficial mutations operate in the same phenotypic space, we suggest that application of the framework developed here will yield dividends equally applicable to the molecular basis of Darwinian evolution.
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